Poseida Therapeutics, Inc.

Delisted

CIK 1661460fmd_1GV4VEYB0AW0SEFQT7STR956V8Manufacturing · Biological Products, (No Diagnostic Substances)Template: Standard

Coverage: Jan 01, 2019 to Sep 30, 2024, 23 periods

News summary

An AI model writes the summary on request, from this company's recent filings only, and cites each filing it uses.

AI-written

Event typeImportance0 filings

From 8-K filings, not wire news: the items each filer selected on the EDGAR cover, grouped by event type. Importance is FinancialMD's own rule by item number (5: bankruptcy, non-reliance, change of control, delisting, cybersecurity; 1: exhibits only).